Method for determining the anti-tumor efficacy of monoclonal...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 49/00 (2006.01)

Patent

CA 2735298

The present invention relates to a method for determining the anti-tumor efficacy of monoclonal antibodies in preclinical rodent testings and the use of said method for the reduction of side testings.

La présente invention concerne un procédé de détermination de l'efficacité anti-tumorale d'anticorps monoclonaux dans des essais pré-cliniques sur des rongeurs et l'utilisation dudit procédé pour la réduction des tests latéraux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for determining the anti-tumor efficacy of monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for determining the anti-tumor efficacy of monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the anti-tumor efficacy of monoclonal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1788573

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.